Wiinberg Ulf

Wiinberg Ulf is listed in filings as Director at MiNK Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including 12 public disclosures. Recent filings connect the profile to MiNK Therapeutics, Inc. (INKT) and Agenus Inc. (AGEN). The current snapshot covers public activity from Jul 1, 2024 to Jun 2, 2026. Reported amounts are shown as $14.0K to $49.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.